|
1
|
Gratwohl A, Baldomero H, Aljurf M,
Pasquini MC, Bouzas LF, Yoshimi A, Szer J, Lipton J, Schwendener A,
Gratwohl M, et al: Worldwide network of blood and marrow
transplantation. Hematopoietic stem cell transplantation: A global
perspective. JAMA. 303:1617–1624. 2010.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Moss P and Rickinson A: Cellular
immunotherapy for viral infection after HSC transplantation. Nat
Rev Immunol. 5:9–20. 2005.PubMed/NCBI View
Article : Google Scholar
|
|
3
|
Ljungman P, de la Camara R, Robin C,
Crocchiolo R, Einsele H, Hill JA, Hubacek P, Navarro D, Cordonnier
C and Ward KN: 2017 European Conference on Infections in Leukaemia
group. Guidelines for the management of cytomegalovirus infection
in patients with haematological malignancies and after stem cell
transplantation from the 2017 European conference on infections in
leukaemia (ECIL 7). Lancet Infect Dis. 19:e260–e272.
2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Teira P, Battiwalla M, Ramanathan M,
Barrett AJ, Ahn KW, Chen M, Green JS, Saad A, Antin JH, Savani BN,
et al: Early cytomegalovirus reactivation remains associated with
increased transplant-related mortality in the current era: A CIBMTR
analysis. Blood. 127:2427–2438. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Zhou X, Jin N and Chen B: Human
cytomegalovirus infection: A considerable issue following
allogeneic hematopoietic stem cell transplantation. Oncol Lett.
21(318)2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Erard V, Guthrie KA, Seo S, Smith J, Huang
M, Chien J, Flowers ME, Corey L and Boeckh M: Reduced mortality of
cytomegalovirus pneumonia after hematopoietic cell transplantation
due to antiviral therapy and changes in transplantation practices.
Clin Infect Dis. 61:31–39. 2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ljungman P, Boeckh M, Hirsch HH, Josephson
F, Lundgren J, Nichols G, Pikis A, Razonable RR, Miller V and
Griffiths PD: Disease Definitions Working Group of the
Cytomegalovirus Drug Development Forum. Definitions of
cytomegalovirus infection and disease in transplant patients for
use in clinical trials. Clin Infect Dis. 64:87–91. 2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Rozy A, Duk K, Szumna B, Skronska P,
Gawryluk D and Chorostowska-Wynimko J: Effectiveness of PCR and
immunofluorescence techniques for detecting human cytomegalovirus
in blood and bronchoalveolar lavage fluid. Adv Exp Med Biol.
921:21–26. 2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Seok JY, An J, Ha SY, Chung DH, Lee S and
Kim H: Morphologic analysis of cytomegalovirus infected cells in
bronchial washing cytology: Comparison of liquid-based preparation
and conventional smear. J Pathol Transl Med. 50:147–154.
2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Elfeky R, Lazareva A, Qasim W and Veys P:
Immune reconstitution following hematopoietic stem cell
transplantation using different stem cell sources. Expert Rev Clin
Immunol. 15:735–751. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Alexandersson A, Koskenvuo M, Tiderman A,
Lääperi M, Huttunen P, Saarinen-Pihkala U, Anttila VJ,
Lautenschlager I and Taskinen M: Viral infections and immune
reconstitution interaction after pediatric allogenic hematopoietic
stem cell transplantation. Infect Dis (Lond). 51:772–778.
2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Li Y, Guptill JT, Russo MA, Massey JM,
Juel VC, Hobson-Webb LD, Howard JF, Chopra M, Liu W and Yi JS:
Tacrolimus inhibits Th1 and Th17 responses in MuSK-antibody
positive myasthenia gravis patients. Exp Neurol. 312:43–50.
2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Melamed IR, Borte M, Trawnicek L,
Kobayashi AL, Kobayashi RH, Knutsen A, Gupta S, Smits W,
Pituch-Noworolska A and Strach M: Pharmacokinetics of a novel human
intravenous immunoglobulin 10% in patients with primary
immunodeficiency diseases: Analysis of a phase III, multicentre,
prospective, open-label study. Eur J Pharm Sci. 118:80–86.
2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Alexander BT, Hladnik LM, Augustin KM,
Casabar E, McKinnon PS, Reichley RM, Ritchie DJ, Westervelt P and
Dubberke ER: Use of cytomegalovirus intravenous immune globulin for
the adjunctive treatment of cytomegalovirus in hematopoietic stem
cell transplant recipients. Pharmacotherapy. 30:554–561.
2010.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Malagola M, Greco R, Santarone S, Natale
A, Iori AP, Quatrocchi L, Barbieri W, Bruzzese A, Leotta S, Carotti
A, et al: CMV management with specific immunoglobulins: A
multicentric retrospective analysis on 92 allotransplanted
patients. Mediterr J Hematol Infect Dis.
11(e2019048)2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Törlén J, Gaballa A, Remberger M, Mörk LM,
Sundberg B, Mattsson J and Uhlin M: Effect of graft-versus-host
disease prophylaxis regimens on T and B cell reconstitution after
allogeneic hematopoietic stem cell transplantation. Biol Blood
Marrow Transplant. 25:1260–1268. 2019.PubMed/NCBI View Article : Google Scholar
|
